BIOMEET SESSIONS 2022 – Impacto da Pandemia na Pessoa com Doença Rara
Dado o panorama mundial face à pandemia causada pelo COVID-19, a P-BIO organizou no passado dia 22 de fevereiro uma sessão dedicada ao impacto causado pela pandemia na pessoa com
GenIbet Biopharmaceuticals
Contract Development Manufacturing Organization (CDMO)
Quilaban
Promoting access to health for more than 40 years with the goal of taking care of the health and wellness of people like us, Quilaban operates in multiple healthcare and
Portugal Biotech 2021 – Tendências, Oportunidades e Desafios no setor da Biotecnologia em Portugal
In 2016, P-BIO promoted a first study on the Portuguese Biotechnology Industry, in terms of firms, labour market and innovation indicators, which acknowledged that the “Portuguese Biotechnology industry is a